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ORIGINAL ARTICLE
The treatment of cervical cancer by radical hys-
terectomy (RH) with or without pelvic radiother-
apy (RT) is well established, and results in an
excellent long-term survival rate. However, uri-
nary dysfunction is a common long-term sequela
after RH. Several studies of preoperative and post-
operative urodynamic data have demonstrated the
adverse effects of RH on urinary tract function.1–4
Nevertheless, the long-term morbidity of lower
urinary tract dysfunction (LUTD) after RH remains
difficult to determine from the available data.
Most patients with cervical cancer treated with
RH receive postoperative bladder care at gynecol-
ogy departments for the inability to empty the
bladder or urinary incontinence by bladder train-
ing, clean intermittent self-catheterization (CISC),
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Management of Lower Urinary Tract
Dysfunction After Radical Hysterectomy
With or Without Radiotherapy for 
Uterine Cervical Cancer
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Background/Purpose: Urinary dysfunction is a common long-term sequela after radical hysterectomy (RH).
The aims of this study were to investigate the characteristics and treatment response of lower urinary tract
dysfunction (LUTD) after RH with or without adjuvant radiotherapy (RT) for uterine cervical cancer.
Methods: We analyzed retrospectively 49 patients who developed LUTD after RH with (n = 16) or without
(n = 33) RT for stage IB or IIA uterine cervical cancer.
Results: The mean interval between RH and first visit for urological management of LUTD was signifi-
cantly shorter in the RH+RT (5.9 ± 4.5 years) than the RH (11.3 ± 9.5; p < 0.05) group. Combined therapy
also resulted in a smaller bladder capacity and poorer bladder compliance. Further urological management
was given to 29 patients, including a pubovaginal sling procedure in seven, urethral injection of botu-
linum toxin A in 13, transurethral incision of the bladder neck in three, and augmentation enterocysto-
plasty in six. Among the patients who received active urological management, 88.9% were satisfied with
the outcome.
Conclusion: Patients treated with RH+RT are likely to have a worse bladder condition and require urologi-
cal intervention sooner than those who receive RH alone. Active urological management of LUTD in these
patients leads to satisfactory improvements in symptoms of difficult urination and urinary incontinence.
[J Formos Med Assoc 2009;108(8):619–626]
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urecholine, or prolonged catheter drainage. How-
ever, initial urological complications may become
chronic or worsen, and new symptoms may also
develop in patients who are managed in these
ways. Close monitoring of lower urinary tract
function and adequate urological management of
LUTD are mandatory to prevent upper urinary
tract dysfunction, and to improve the quality of
life of these patients.
The aims of the present study were to investi-
gate the characteristics of LUTD after RH with or
without RT for uterine cervical cancer and the re-
sults of active management of these conditions
in patients from Eastern Taiwan.
Materials and Methods
This was a retrospective study of 49 patients who
were treated for LUTD after RH with or without
adjuvant RT for stage IB or IIA cervical cancer
from 1997 to 2006. These patients had received
voiding training after RH, which was provided 
by the department of obstetrics and gynecology
in several hospitals, and were referred for further
management to improve quality of life with regard
to urination or for the treatment of urological
complications. After detailed physical examina-
tion, voiding history taking, urinalysis, urine bac-
terial culture, and diagnostic imaging, a complete
urodynamic or videourodynamic study was per-
formed to identify the underlying pathophysiology
of LUTD.
A videourodynamic study was performed 
according to the recommendations of the Inter-
national Continence Society.5 We reviewed pa-
tient chart records and collected data including
the presenting symptoms at the initial urological
visit and videourodynamic findings. Storage dys-
function was detected by the presence of detru-
sor overactivity or intrinsic sphincter deficiency
(ISD). Voiding dysfunction was detected by the
presence of detrusor underactivity, acontractile
detrusor, non-relaxing urethral sphincter, or blad-
der neck dysfunction. Detrusor overactivity is a
urodynamic observation that is characterized by
involuntary detrusor contractions during the fill-
ing phase, which may be spontaneous or pro-
voked. ISD denotes an intrinsic malfunction of
the urethral sphincter itself, and we used abdom-
inal leak point pressure < 60 cmH2O as the objec-
tive measure.6 Detrusor underactivity is defined
as contraction of reduced strength and/or dura-
tion, which results in prolonged bladder empty-
ing and/or failure to achieve complete bladder
emptying within a normal time span. Acontrac-
tile detrusor cannot be demonstrated to contract
during urodynamic studies. Non-relaxing urethral
sphincter obstruction usually occurs in individu-
als with a neurological lesion and is character-
ized by a non-relaxing, obstructing urethra that
results in reduced urine flow. A tight bladder
neck that shows on fluoroscopy during the void-
ing phase signifies bladder neck dysfunction. 
In this study, the results of management of LUTD
according to bladder or urethral dysfunction were
also analyzed. A satisfactory rate was defined as
subjective improvements in symptoms of difficult
urination or urinary incontinence.
The interval between RH and the patient’s
first visit to the urology department for manage-
ment of LUTD, urodynamic findings including
cystometric capacity, bladder compliance and
postvoid residual urine (PVR), as well as various
voiding dysfunctions and resultant complica-
tions, were compared between patients who re-
ceived RH alone and those who received RH+RT.
Student’s t tests and χ2 tests were used for statisti-
cal analysis. Statistical significance was assumed
when p < 0.05.
Results
Patient characteristics
Forty-nine women who were treated for LUTD
after RH were included in this study. The interval
between RH and initial assessment at the urology
department ranged from 6 months to 30 years.
The interval between RH and initial assessment
was > 1 year and < 10 years in 38.8% of patients,
and 10–30 years in 36.6%. Difficulty in urination
F.C. Chuang, H.C. Kuo
620 J Formos Med Assoc | 2009 • Vol 108 • No 8
(69.4%) and urinary incontinence (55.1%) were
the most common urinary symptoms, followed by
frequent urinary tract infection (UTI) (30.6%) and
urinary frequency and urgency (30.6%). Table 1
shows the characteristics of the patients in the
RH and RH+RT groups. There were 33 women
treated with RH alone and 16 with RH+RT. The
mean age at the time of RH was 48.9 ± 11.3 years
in the RH group and 51.2 ± 8.4 years in the
RH+RT group (p = 0.473). The mean interval be-
tween RH and first visit to the urology depart-
ment for treatment of LUTD was 11.3 ± 9.5 years
and 5.9 ± 4.5 years in the RH and RH+RT groups,
respectively (p < 0.05).
Urodynamic findings
The RH group had significantly larger cystomet-
ric capacity than the RH+RT group (mean, 331 ±
139 mL vs.38 ± 111 mL; p = 0.024). The difference
in bladder compliance between the two groups
was not significant, but the incidence of low and
poorly compliant bladder (< 10 mL/cmH2O) was
significantly higher in the RH+RT group (7/16,
43.8%) than in the RH group (5/33, 15.2%;
p < 0.05). There was no significant difference be-
tween the two groups for the incidence of a large
PVR (> 100 mL), incontinence, dysuria, hydro-
nephrosis, vesicoureteral reflux, or frequent UTI
(Table 1).
The results of the videourodynamic study are
shown in Table 2. There was no significant dif-
ference in the incidence of bladder dysfunction
between patients in the RH and RH+RT groups.
Patients with detrusor underactivity or acontrac-
tile detrusor comprised 85.7% of all the patients
in the study. Detrusor overactivity was found in
10.2% of patients, while normal detrusor func-
tion was found in only 4.1%. The incidence of
urethral dysfunction, ISD and non-relaxing ure-
thral sphincter were not significantly different 
between the RH and RH+RT groups. Only 14.3% 
of patients had normal urethral function.
Urological management of LUTD
The patients were treated according to their blad-
der and urethral dysfunctions. Previously, LUTD
was managed conservatively with self-voiding by
the clock, Crede maneuver or abdominal strain-
ing, medication, pelvic floor muscle training,
CISC, or indwelling catheterization. When these
conservative treatments failed to relieve their
LUTD, active urological management was under-
taken, including pubovaginal sling procedure for
ISD in seven patients (5 with RH, 2 with RH+RT),
urethral sphincter injection of botulinum toxin
A (BTX-A) for non-relaxing urethral sphincter 
in 13 (11 with RH, 2 with RH+RT), transurethral
incision of the bladder neck (TUI-BN) for a tight
LUTD after RH with or without RT
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Table 1. Comparison of characteristics of patients treated with RH and RH+RT*
RH (n = 33) RH+RT (n = 16) p
Age at RH (yr) 48.9 ± 11.3 51.2 ± 8.4 0.473
Interval between RH and first visit to 11.3 ± 9.5 5.9 ± 4.5 0.039
urology department (yr)
Cystometric capacity (mL)† 331 ± 139 238 ± 111 0.024
Bladder compliance† 70 ± 108 18 ± 14 0.063
Large PVR (≥ 100 mL)† 17 (51.5) 4 (25) 0.078
Incontinence 18 (54.5) 9 (56.3) 0.912
Difficult urination 23 (69.7) 11 (68.8) 0.947
Hydronephrosis 9 (27.3) 7 (43.8) 0.247
Vesicoureteral reflux 5 (15.2) 1 (6.3) 0.372
Frequent UTI 10 (30.3) 5 (31.3) 0.947
*Data presented as mean ± standard deviation or n (%); †urodynamic parameters. RH = radical hysterectomy; RH+RT = radical 
hysterectomy plus adjuvant radiotherapy; PVR = postvoid residual urine; UTI = urinary tract infection.
bladder neck in three (2 with RH, 1 with RH+RT),
and augmentation enterocystoplasty for a con-
tracted bladder, with or without vesicoureteral
reflux in six (3 with RH, 3 with RH+RT) (Table 3).
All seven patients who received the pubovagi-
nal sling procedure had urinary continence for at
least 3 months, but five needed CISC because of
chronic urinary retention during the initial post-
operative period. One patient treated with pubo-
vaginal sling required two repeats of the same
procedure because of failure to achieve conti-
nence, at intervals of 3 months and 3 years. Four
patients, including two with RH and two with
RH+RT, had recurrent mild stress urinary incon-
tinence at > 6 months after the pubovaginal sling
procedure. All of these conditions were attributed
to poor bladder compliance with low urethral 
resistance that led to overflow incontinence. De-
spite these problems, the overall satisfaction rate
of the pubovaginal sling procedure was 85.7%
(6/7 continent for > 3 months).
Among the 13 patients who received peri-
urethral injection of BTX-A, five showed smooth
voiding with less abdominal straining and mini-
mal PVR. However, two of these patients experi-
enced exacerbated stress urinary incontinence and
nocturnal enuresis after the procedure. Neverthe-
less, they were not dissatisfied with this outcome
because of the overall improvement in voiding
symptoms. One patient treated with RH+RT had
six repeat injections of BTX-A at 6-month in-
tervals. She was satisfied with the easier voiding
that resulted from the procedure, despite an epi-
sode of postoperative urethral edema and initially
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Table 2. Pathophysiology of voiding dysfunction disclosed by videourodynamic study*
RH (n = 33) RH+RT (n = 16) p Total (n = 49)
Bladder function
DU 30 (90.9) 12 (75) 0.137 42 (85.7)
DO 2 (6.1) 3 (18.8) 0.168 5 (10.2)
ND 1 (3.0) 1 (6.3) 0.56 2 (4.1)
Urethral function
ISD 12 (36.4) 8 (50) 0.362 20 (40.8)
Non-relaxing urethral sphincter 16 (48.5) 6 (37.5) 0.47 22 (44.9)
NU 5 (15.2) 2 (12.5) 0.443 7 (14.3)
*Data presented as n (%). RH = radical hysterectomy; RH+RT = radical hysterectomy plus adjuvant radiotherapy; DU = detrusor 
underactivity; DO = detrusor overactivity; ND = normal detrusor function; ISD = intrinsic sphincter deficiency; NU = normal urethral
function.
Table 3. Active urological management for lower urinary tract dysfunction after RH with or without RT for 
uterine cervical cancer
Urological management Indication
Total number 
Satisfaction rate
(RH/RH+RT)
Pubovaginal sling procedure ISD 7 (5/2) 85.7% (6/7)
Urethral sphincter injection of Non-relaxing urethral 13 (11/2) 81.8% (9/11)*
botulinum toxin A sphincter
Transurethral incision of the Tight bladder neck 3 (2/1) 100% (3/3)
bladder neck
Augmentation enterocystoplasty Contracted bladder with or 6 (3/3) 100% (6/6)
without vesicoureteral reflux
*Two patients were lost to follow-up. RH = radical hysterectomy; RH+RT = radical hysterectomy plus adjuvant radiotherapy;
Satisfaction rate = improvements in symptoms of difficult urination or urinary incontinence; ISD = intrinsic sphincter deficiency.
difficult urination. CISC was still needed in four
patients with significantly improved lower uri-
nary tract symptoms and voiding efficiency after
BTX-A injection. Further examination revealed
that two of these patients had bladder neck dys-
function, and subsequent TUI-BN resulted in im-
provement in lower urinary tract symptoms and
voiding efficiency. The first BTX-A injection did
not lead to improvements in two patients treated
with RH, one of whom reported fair improve-
ment after a second injection 3 weeks later. The
other two patients were lost to follow-up after
the initial BTX-A injection. Excluding the two pa-
tients who were lost to follow-up, the satisfac-
tion rate with BTX-A injection was 81.8% (9/11,
subjective improvements in symptoms of difficult
urination).
Augmentation enterocystoplasty was per-
formed for contracted bladder with upper uri-
nary tract deterioration in six women, including
three in the RH group, and three in the RH+RT
group. The interval between RH and enterocysto-
plasty ranged from 1 to 11 years. All of these 
patients had good resolution of hydronephrosis
and increased bladder capacity after enterocysto-
plasty. CISC was a necessary adjuvant management
after enterocystoplasty in all of these patients be-
cause of acontractile detrusor and non-relaxing
urethral sphincter. Two patients received peri-
urethral injection of BTX-A and TUI-BN for uri-
nation difficulties, and no longer needed CISC
after these further treatments. One patient in the
RH+RT group required repeat enterocystoplasty as
a result of contracture of the previous augmented
bladder 4 years after the initial procedure. After
the second enterocystoplasty, her condition re-
mained stable for > 4 years. All patients who un-
derwent enterocystoplasty had a successful result,
as defined by reported satisfaction. In this study,
84.2% of patients treated with RH, and all those
treated with RH+RT who received active urologi-
cal management, were satisfied with their out-
come, mainly because of improved quality of life.
The overall satisfaction rate of active urological
management of LUTD after RH with or without
RT for uterine cervical cancer was 88.9%.
Discussion
This retrospective analysis included 49 patients
who underwent RH with or without RT for cervi-
cal cancer and subsequent treatment for LUTD.
The interval between RH and the urological inter-
vention was 1–30 years. The urological evaluation
and intervention in this study were relatively late
after RH, and the urological symptoms could
therefore be considered as long-term complica-
tions of RH or RH+RT. Woodside and McGuire
reported that 92% of patients who underwent
RH had normal voiding at 1 year after surgery.7
Other studies have reported that urinary symp-
toms persisted in 20–50% of patients after RH,
and consisted mainly of urinary incontinence,
impaired bladder sensation, UTI, and straining
on voiding.8,9 A small fraction of patients who
undergo RH or RH+RT for cervical cancer might
develop long-term LUTD, which may be caused by
neurological insult sustained during radical pelvic
surgery and compounded by adjuvant irradia-
tion or poor postoperative bladder care. Lin et al
demonstrated that abnormal urodynamic find-
ings exist in some patients with cervical cancer
before treatment, and that these findings may
worsen, and/or additional abnormal states may
arise subsequent to RH.10,11
In the present study, patients who received
RH+RT compared with RH alone had a shorter
interval between RH and urological evaluation
for LUTD, and had a smaller cystometric capacity
and higher incidence of low and poor bladder
compliance. These findings are similar to those
of previous studies12,13 and suggest that RT can
have a significant impact on lower urinary tract
function. Patients who undergo RH with adju-
vant RT need careful surveillance for LUTD, and
early urological intervention may be necessary to
improve quality of life.
Fraser reported that a significant amount of
PVR was present in 50% of patients at 5–15 years
after RH, and was correlated significantly with
impaired bladder sensation, difficult urination,
and UTI.14 In our study, PVR > 100 mL was noted
in 21 of 49 (42.9%) patients, with a similar
LUTD after RH with or without RT
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prevalence in the two treatment groups. Large
PVR can result in many complications such as
frequent UTI, urinary incontinence, increased
frequency and urgency of urination, and upper
urinary tract deterioration.
The functional changes in the bladder and ure-
thra after RH are multifarious. The final changes in
lower urinary tract function may also vary among
patients. In general, bladder dysfunction immedi-
ately after RH consists of a hypertonic and poorly
compliant bladder, reduced bladder capacity, and
diminished bladder sensation.2,3 Anatomical fac-
tors such as perivesical adhesion and intrinsic
myogenic tonic change are thought to play a
major role in early postoperative bladder dysfunc-
tion.3,15 In the present study, 85.7% of patients
presented with either detrusor underactivity or
an acontractile detrusor, while only 10.2% had
detrusor overactivity, and 4.1% had normal detru-
sor function. Detrusor hypotonicity was thought
to be caused by parasympathetic and sympathetic
denervation in the pelvic plexus. The most likely
etiology of late detrusor hypertonicity after RH is
an alteration of bladder innervation. A relatively
normal detrusor function reflects partial dener-
vation of the peripheral autonomic nerves, with
intact autoregulation and coordination of the
autonomic system.3 Different kinds of neurolog-
ical insult sustained during RH and dissection of
bilateral lymph nodes can result in complete or
incomplete denervation of the autonomic nerves
that supply the lower urinary tract.3,16
In the present study, the prevalence of isolated
sphincter obstruction and ISD was about equal in
the RH and RH+RT groups. Non-relaxing urethral
sphincter may result from altered modulation by
the pelvic plexus and the resulting motor and
sensory impairment of the detrusor.17–20 ISD may
be the result of a deficit in bladder neck support,
partial loss of alpha-adrenergic tone in the prox-
imal urethra, complete autonomic denervation,
aging, or weakened pelvic-floor musculature.19–21
The multifarious combination of detrusor and
urethral dysfunction needs precise classification
because of its clinical importance for the treatment
and prevention of late urological complications.
After RH, patients have to learn a new method
of voiding and have to use the bathroom at regu-
lar intervals. Voiding dysfunction that is char-
acterized by straining to void without detrusor
contraction and a non-relaxing urethral sphinc-
ter can result in difficulty in urination, large PVR,
and subsequent UTI. CISC has been used widely
to manage this LUTD, but it is not a convenient
method for all patients. Medication with alpha-
adrenergic blockers and skeletal muscle relaxants
to relieve bladder neck dysfunction and external
sphincter tone may be helpful in some cases, but
the side effects of these drugs may not be tolera-
ble.22 Urethral injection of BTX-A to treat patients
with voiding dysfunction caused by detrusor un-
deractivity and non-relaxing urethral sphincter
after RH is a new therapy to reduce urethral re-
sistance. Kuo reported that this treatment had an
80% success rate in facilitating efficient voiding,
with few adverse effects.23 Poor response to ure-
thral BTX-A injection might be caused by high
urethral sphincter tone, and repeat injections in
the early stage might be necessary. Bladder neck
dysfunction may be another site of functional
obstruction in addition to the urethral sphincter.
Careful interpretation of cystourethrography dur-
ing the voiding phase is important.23,24
Urinary incontinence may be a protective
method for the upper urinary tract because a
high leak-point pressure can produce vesico-
urethral reflux and subsequent hydronephrosis.
However, urinary incontinence is associated with
a worse quality of life. Thus, the need for preser-
vation of renal function and improved quality 
of life requires careful balancing when selecting
treatment. The obstructive effect of a suburethral
sling may become prominent in patients with
detrusor underactivity or an acontractile detru-
sor, and may lead to the complication of chronic
urinary retention. Patients with detrusor under-
activity or an acontractile detrusor usually void
with the aid of abdominal straining, and low ure-
thral resistance is often necessary for voiding by
abdominal straining. Before surgery, it is necessary
to make sure that the patient has sufficient en-
ergy to produce abdominal pressure to overcome
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urethral resistance. Kuo reported that patients
with detrusor underactivity or an acontractile 
detrusor had a higher rate of recurrent stress in-
continence (36%) and difficulty with urination
(36%) after a suburethral sling procedure.25 In the
present study, four patients, including two in the
RH+RT group, developed overflow incontinence
after the sling procedure because of poor bladder
compliance and low urethral resistance. In addi-
tion to detrusor and urethral dysfunction, bladder
compliance and capacity should be considered
when developing a treatment strategy for LUTD.
As LUTD may change with time in such patients,
careful follow-up is mandatory.
When RH leads to the complications of low
bladder compliance and contraction, high intra-
vesical pressure, vesicoureteral reflux, and hydro-
nephrosis, an aggressive therapeutic strategy to
rescue the patient from impending renal insuffi-
ciency is necessary. Enterocystoplasty is effective
for the treatment of neuropathic contracted blad-
der if the patient has the ability to perform CISC
for the likely difficulty in emptying the bladder
after surgery.22 Difficult urination, UTI and stone
formation are possible complications that may
be encountered after enterocystoplasty. Neverthe-
less, this treatment provides the chance to pre-
serve renal function and improve quality of life.
The present study shows that enterocystoplasty is
a feasible method for the treatment of contracted
bladder in patients who have undergone RH
with or without RT.
Patients treated with RH+RT are likely to have
a worse bladder condition and require urological
intervention sooner than those who receive RH
alone. Active urological management for LUTD
after RH with or without RT for uterine cervical
cancer had a satisfactory success rate with regard
to improvements in symptoms of difficult urina-
tion and urinary incontinence.
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